ResMed (ASX:RMD) shares have underperformed the broader market this calendar year, as COVID-related supply constraints have impacted revenue and margins. We recently researched the Company to assess the extent and timing of any improvement and accordingly, whether the current weakness in the shares presents an attractive opportunity. About ResMed ResMed provides products for the treatment of sleep-related breathing disorders, including sleep apnea, Chronic Obstructive Pulmonary Disease (COPD), and other respiratory conditions. The product portfolio has traditionally included airflow generators, nasal …

Read MoreWhen is it time to buy ResMed?

We recently researched Bank of Queensland (ASX:BOQ) to assess whether the recent share price weakness presents an attractive entry opportunity. About Bank of Queensland Bank of Queensland offers core banking (commercial/retail) services, equipment finance, wealth management and insurance. BOQ uses its unique concept of the Owner-Managed Branch. This is a partnership between the Bank of Queensland (franchisor) and experienced bank managers (franchisees) to provide banking services. The bank operates in two segments – the Retail Bank and the Business Banking …

Read MoreIs Bank of Queensland a value trap?